Conferenze mediche in Ucraina

Stem cells have shown tremendous promise for understanding and treating a range of intractable diseases, Conferenze mediche in Ucraina. Conferenze mediche in Ucraina, and each day moves researchers closer to another medical breakthrough.


Stem cells have demonstrated encouraging potential as reparative therapy for patients

The current review summarises the current evidence for use of stem cell therapies. The safety and feasibility of administering different types of stem cell therapies seem to be reasonably proven and all clinical data included in the Global DataBase (Stati Uniti d'America) mesenchymal+stem+cells&Search=Apply&recrs=e&age_v=&gndr=&type=&rslt=

We examined the reports of clinical trials in the NIH and European databases to classify them by stem cell type and disease application.

We searched for clinical trial data published in peer-reviewed journals and sought out publically available information on trials performed by companies. Data for some studies are regularly published, but for many trials data are unavailable or not easily accessed. Given the relative immaturity of the cell therapy field, it is important to know the outcomes of early clinical trials to help guide others in the processes.

MSCs for Liver Disease and Diabetes

Liver in end stage liver disease (cirrosi) due to hepatitis B and C and alcoholic and cryptogenic causes showed some response in function as assessed by changes in creatinine, serum albumin, and bilirubin in response to autologous MSCs (El-Ansary et al., 2012, Kharaziha et al., 2009).


The anti-fibrotic effects of autologous MSCs (which were 50 million MSCs administered on two occasions 4 weeks apart) were explored in patients with alcoholic liver cirrhosis (Jang et al., 2014). Improvements in histological liver biopsy samples were observed in 55% patients as well as some change in type-1 collagen and α-smooth muscle actin.



Diabetes is classified into two main types (genere 1 e digita 2) which both lead to hyperglycemia .

Types of diabetes

  1. Tipo 1 Diabetes is the result of a person’s immune system fighting and destroying the b-cells, it usually begins in the early stages of life and accounts for 10% of the total cases of diabetes. People with this type have to take insulin shots daily in order to survive.
  2. Tipo 2 Diabetes results from b-cell performance decline and an increase in insulin resistance; this type is linked with genetic factors and obesity, hence this type can be prevented by living a healthy lifestyle.
  3. There is another type of diabetes that affects pregnant women, it is called Gestational Diabetes where the hormones released by the placenta to sustain the pregnancy, make the pregnant woman’s cells more resistant to insulin. Once the pancreas is unable to overcome the resistance, the patient develops diabetes

Diabete Trattamento con cellule staminali

Over the years, there have been attempts to cure diabetes by using methods like replacing b-cells through transplants, by increasing b-cell replication, by reducing the death of b-cells and by deriving new b-cells from other cells.

Autologous Mesenchymal stem cells (MSC) are self-renewing multipotent cells that have the capacity to secrete multiple biologic factors that can restore and repair injured tissues.

It is known that MSCs play a crucial role in healing damaged tissues. They can differentiate to replace the dead cells as well as secrete stimulant factors to activate surrounding cells in the microenvironment, enhancing the tissue repair process. Perciò, MSCs can be applied to treat tissues impaired by chronic hyperglycemia. MSC transplantation can increase beta cell mass via the following effects:

(1) beta cell replacement through cellular differentiation;

(2) local microenvironment modification by production of cytokines, chemokines and factors to stimulate endogenous regeneration;

(3) reduction or prevention of autoimmunity to beta cells. Immunomodulatory and inflammatory effects of MSCs also contribute to the reduction of insulin resistance.

Results achieved with terapia con cellule staminali

  • Significant decrease in fasting blood sugars and the level of Hemoglobin A1C
  • Significant decrease in Triglyceride levels
  • Measurable improvement in kidney function with a decrease in creatinine levels


Clinical studies are underway using MSCs in patients with diabetes.

Data suggest positive changes in metabolic parameters may occur with intravenous injection MSCs

It is known that MSCs play a crucial role in healing damaged tissues. They can differentiate to replace the dead cells as well as secrete stimulant factors to activate surrounding cells in the microenvironment, enhancing the tissue repair process

The recent progress in regenerative medicine, especially terapia con cellule staminali, has suggested several novel and potential cures for (Diabetes Type 1) T1D. Autologous mesenchymal stem cell (MSC) based cell therapy is among one of them. MSCs are a type of adult stem cells residing in bone marrow, il tessuto adiposo, umbilical cord blood, and many other tissues. MSC, with self-renewal potential and transdifferentiation capability, can be expanded in vitro and directed to various cell lineages with relatively less efforts. MSCs have well-characterized hypoimmunogenicity and immunomodulatory effect. All these features make MSCs attractive for treating T1D.

For both T1DM and T2DM, autologous MSC transplantation can dramatically improve the blood glucose levels, while reducing the insulin dose and side effects associated with DM. More importantly, both in preclinical trials and clinical trials, autologous MSC transplantation has been demonstrated to be safe; there have been no observed adverse side effects or tumorigenesis. The data thus far have suggested that MSC transplantation is a promising therapy for DM mesenchymal+stem+cells&recrs=e&draw=8&rank=80 mesenchymal+stem+cells&recrs=e&draw=9&rank=84


Efficacy of autologous stem cell transplantation in patients with type 2 Diabete mellito.

Our observations indicate that SCT is a safe and effective modality of treatment to improve beta-cell function in patients with T2DM.

MSC treatment demonstrated exciting therapeutic effects on glycemic control by restoring islet function and ameliorating insulin resistance

Stem cell therapies in clinical trials in stroke


Osteoarthritis and knee pain

Feasibility and safety were confirmed, and strong indications of clinical efficacy were identified. Patients exhibited rapid and progressive improvement of algofunctional indices that approached 65% a 78% di 1 anno. MSC therapy may be a valid alternative treatment for chronic knee osteoarthritis. The intervention is simple, does not require hospitalization or surgery, provides pain relief, and significantly improves cartilage quality.

Intra-articular injection of MSCs in osteoarthritic patients resulted in strong improvement in cartilage coverage and quality in the vast majority of treated cases (Orozco et al., 2013)


Mal di schiena

Patients with severe back pain due to degenerative disc disease improved dramatically, Parte medica della fabbrica Artem 71% of optimal efficiency in the improvement of clinical parameters of pain and disability, but without disc height recovery (Orozco et al., 2011).


Mesoblast has also reported the benefits of a single injection of MSCs (6 o 18 milioni) in a randomized, placebo-controlled phase II study of 100 patients with chronic low back pain due to degenerative disc disease. A single injection of 6 million MSCs gave substantial and sustained pain relief with 48% having no or minimal pain after 24 months compared with only 13% of patients without pain who received saline control injections (Mesoblast, 2015)


Disfunzione erettile

Clinical trial results show that stem cells can restore sufficient erectile function to allow previously impotent men to have spontaneous intercourse. This is the first time terapia con cellule staminali has produced patients who have recovered sufficient erectile function to enable intercourse.

In 2016, Haahr et al from Denmark reported on the safety and potential effect of a stem cells injection of autologous ADSCs


Sclerosi multipla

More than half of patients with multiple sclerosis have progressive disease characterised by accumulating disability. The absence of treatments for progressive multiple sclerosis represents a major unmet clinical need. On the basis of evidence that autologous mesenchymal stem cells have a beneficial effect in acute and chronic animal models of multiple sclerosis, we aimed to assess the safety and efficacy of these cells as a potential neuroprotective treatment for secondary progressive multiple sclerosis.

Autologous autologous mesenchymal stem cells were safely given to patients with secondary progressive multiple sclerosis in our study. The evidence of structural, functional, and physiological improvement after treatment in some visual endpoints is suggestive of neuroprotection.


Trattamento con cellule staminali for Lyme disease

Cervello, sistema nervoso, cuore, circolazione, muscoli, articolazioni, sistema riproduttivo, la digestione e la pelle sono alcune aree del corpo colpite dalla malattia di Lyme cronica. A volte i sintomi impiegano anche anni per svilupparsi ed è impossibile prevedere quando potrebbero comparire. Queste difficoltà sono molto difficili da risolvere, lasciando un paziente sofferente e disabile per le normali attività quotidiane.

Nuovo terapia con cellule staminali è una scoperta estremamente utile per tutti i pazienti con malattia di Lyme la cui condizione è progredita e ha lasciato loro un danno che causa sintomi che non possono essere risolti.

. Fanno parte di un sistema di riparazione e durante questa procedura vengono arricchiti e il loro numero ampliato, ecco perché sono in grado di ricostruire maggiormente le aree danneggiate all'interno dell'organismo, in modo del tutto naturale, invertire i sintomi di una condizione.


autologo Terapia con cellule staminali è completamente sicuro

Stem cells are undifferentiated cells that are give rise to differentiated cells that make up the building blocks of tissue and organs. Due to their unlimited source and high differentiation potential, autologous stem cells are considered as potentially new therapeutic agents for the treatment.

During past few years a considerable progress in stem cell-based strategies whole body regeneration have been proposed as future clinical therapies.

Attualmente, most procedures involve injections of stem cells to peripheral blood like a blood transfusions.

Quando le cellule staminali vengono infuse nel paziente, sono somministrati attraverso un catetere endovenoso (IV) proprio come una trasfusione di sangue.

Pre-Treatment Evaluation

A stem cell specialist will begin the evaluation by reviewing your medical record and history, performing anti-aging treatment he will recommend a treatment plan.

Test di preammissione

Prima di essere ricoverato in clinica, you will have laboratory and other diagnostic tests to determine if you have normal function of the heart, polmoni, reni e fegato e di non avere un'infezione non diagnosticata. La maggior parte di questi test verrà eseguita in regime ambulatoriale prima del tuo ricovero in clinica, ma altri potrebbero dover essere completati dopo il tuo ricovero per il trattamento.


Stem Cells injections.

Quando le cellule staminali vengono infuse nel paziente, sono somministrati attraverso un catetere endovenoso (IV) o catetere venoso centrale, proprio come una trasfusione di sangue .


It is expected strengthening the regenerative abilities of the body, improving of all functions of organs and tissues and repairing of pathologically damaged tissues, rejuvenate body.

The approximate maximum of stem cell efficiency is 2 months after injection with the subsequent long-term effect.



It is recommended do not use antibiotics for several weeks after stem cells injections.

It is not recommended to visit sauna for 1-2 settimane, avoid strong physical activity, stresses and any kind of trauma within 2 months after stem cells injections.

Hai bisogno di maggiori dettagli?

Contatta Dr. Eugene Zadorin

trattamento con cellule staminali Ucraina


WhatsApp +380632776465




Terapia con cellule staminali Ucraina
tipo di servizio
Nome del provider
Clinica delle cellule staminali NBS,
Kiev,Ucraina- Telefono n.380632776465
La zona
terapia con cellule staminali